| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/10/2004 | WO2004004756A8 Use of pthrp antagonists for treating renal cell carcinoma |
| 06/10/2004 | WO2004004698A3 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 06/10/2004 | WO2004003145A3 Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
| 06/10/2004 | WO2004001008A3 Kinases and phosphatases |
| 06/10/2004 | WO2003106632A3 Inhibitors of inflammatory gene activity and cholesterol biosynthesis |
| 06/10/2004 | WO2003106476A8 Nucleic acid mediated inhibition of enterococcus infection and cytolysin toxin activity |
| 06/10/2004 | WO2003104266A3 PEPTIDES AND PEPTIDOMIMETICS USEFUL FOR INHIBITING THE ACTIVITY OF PROSTAGLANDIN F2alpha RECEPTOR |
| 06/10/2004 | WO2003102140A3 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis |
| 06/10/2004 | WO2003089571A3 Ehrlichia canis genes and vaccines |
| 06/10/2004 | WO2003087373A3 Production of recombinant fragments of muscle acetylcholine receptor and their use for ex vivo immunoadsorption of anti-ach receptor antibodies from myasthenic patients |
| 06/10/2004 | WO2003087307A3 Use of interleukin-19 to treat cervical cancer |
| 06/10/2004 | WO2003087158A3 Regulation of human transient receptor potential channel |
| 06/10/2004 | WO2003087157A9 Differentially expressed genes involved in angiogenesis, the proteins encoded thereby, and methods of using the same |
| 06/10/2004 | WO2003083039A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/10/2004 | WO2003074060A8 Dna demethylase antisense and chemotherapy combination |
| 06/10/2004 | WO2003070970A3 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA) |
| 06/10/2004 | WO2003066842A3 Method for producing recombinant proteins in micro-organisms |
| 06/10/2004 | WO2003044057A3 Use of obg3 for promoting central nervous system remyelination |
| 06/10/2004 | WO2003039346A9 Diagnostics and therapeutics for ocular abnormalities |
| 06/10/2004 | WO2003037267B1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 06/10/2004 | WO2003037258A3 Methods and compositions for the treatment and diagnosis of pain disorders using 2047 |
| 06/10/2004 | WO2003029406A3 USE OF HIF-1α VARIANTS TO ACCELERATE WOUND HEALING |
| 06/10/2004 | WO2003026689A8 Autologous growth factor cocktail composition, method of production and use |
| 06/10/2004 | WO2003015711A3 Combination motif immune stimulatory oligonucleotides with improved activity |
| 06/10/2004 | WO2003007800A9 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 06/10/2004 | WO2003002606A3 Nucleic acids encoding ion channels |
| 06/10/2004 | WO2002090600A3 A method for regulating immune function in primates using the foxp3 protein |
| 06/10/2004 | WO2002038168A3 Use of selectin-binding active ingredients for the treatment of inflammatory and tumoral diseases |
| 06/10/2004 | US20040110941 by cloning, amplifying and expressing DNA sequences using polymerase chain reaction; for therapy, diagnosis or catalysis; solid phase synthesis |
| 06/10/2004 | US20040110940 Novel nucleic acids and polypeptides |
| 06/10/2004 | US20040110938 Comprises nucleotide sequences coding peptides for use in detection, screening and prognosis of psychological disorders and treatments |
| 06/10/2004 | US20040110935 Universal carrier for targeting molecules to Gb3 receptor expressing cells |
| 06/10/2004 | US20040110934 Human mitochondrial proteins and polynucleotides encoding the proteins |
| 06/10/2004 | US20040110932 Comprises polypeptide agent of Class I cytokine receptor subfamily for prevention and treatment cell proliferation disorders; antitumor agents |
| 06/10/2004 | US20040110928 Peptide conjugates for drug delivery |
| 06/10/2004 | US20040110927 Expression vector coding secretory peptide antisense sequences for gene therapeutic treatment of tumors; antitumor agents |
| 06/10/2004 | US20040110926 Comprises nucleotide sequences coding interleukin receptor associated kinase-2 (IRAK-2) for diagnosis and treatment of infections; solid tumors; leukemias; alzheimer's and autoimmune disorders |
| 06/10/2004 | US20040110923 Nucleic acid binding polypeptides |
| 06/10/2004 | US20040110922 Comprises nucleotide sequences coding viral envelope glycoprotein 120 for diagnosis, prevention and treatment of viral diseases; viricides |
| 06/10/2004 | US20040110921 Comprises chordin-like polypeptide fo diagnosis, pre vention and treatment of bone and cancer disorders; gene therapy; antitumor agents |
| 06/10/2004 | US20040110920 Novel g protein-coupled receptor protein and dna thereof |
| 06/10/2004 | US20040110919 Comprises toxic jellyfish protein for use as pesticide |
| 06/10/2004 | US20040110839 Compounds and compositions for delivering active agents |
| 06/10/2004 | US20040110735 Methods of activating receptor using amphiphilic drug-oligomer conjugates |
| 06/10/2004 | US20040110728 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 06/10/2004 | US20040110715 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 06/10/2004 | US20040110713 Molecular hybridization; gene expression inhibition; treating Scott syndrome and bleeding disorders |
| 06/10/2004 | US20040110711 Novel treatment of neurodegenerative diseases by altering levels of TrkB isoforms and/or TrkC isoforms |
| 06/10/2004 | US20040110709 Genetic modification of the lung as a portal for gene delivery |
| 06/10/2004 | US20040110707 Method of treating neurological diseases |
| 06/10/2004 | US20040110706 Nucleic acid with point mutations, deletions, insertions and/or rearrangements ; hyperthermia, myasthenia, ataxia, neuropathic and inflammatory pain; Alzheimer*s, Parkinson's disease; schizophrenia, hyperekplexia, myotonias and arrhythmia |
| 06/10/2004 | US20040110705 Antisense oligonucleotides targeted to nucleic acids encoding Talin, a cytoplasmic protein; gene expression inhibition |
| 06/10/2004 | US20040110702 Nucleotide hybridizes with nucleic acid encoding MAGE-D1(melanoma antigen); gene expression inhibition |
| 06/10/2004 | US20040110701 Molecular hybridization; nervous system disorder treatment; drug screening, medical diagnosis |
| 06/10/2004 | US20040110700 Nucleotide hybridizes with nucleic acid molecule encoding CD1D and inhibits gene expression; genetic engineering; drug screening |
| 06/10/2004 | US20040110699 Modulation of ABCC2 expression |
| 06/10/2004 | US20040110698 Oligonucleotides and methods using same for treating cox-ll associated diseases |
| 06/10/2004 | US20040110691 Thiol reactive agents as a therapeutic modality |
| 06/10/2004 | US20040110690 Transporter peptide capable of translocating across biological membrane of pancreatic B-cells, hepatocytes, colon cells, muscle cells and/or lung cells; drug delivery; biochemical conjugation |
| 06/10/2004 | US20040110689 Methods for treating hormone associated conditions using a combination of LHRH antagonists and specific estrogen receptor modulators |
| 06/10/2004 | US20040110688 Region of factor IXa protease domain that interacts with factor VIIIa and methods therefor |
| 06/10/2004 | US20040110687 Administering immunomodulatory peptides for side effect reduction from cancer chemotherapy or radiotherapy; diarrhea, mucositis, stomatitis and proctitis |
| 06/10/2004 | US20040110686 Contacting wound with fibrinogen in lipid rich component prepared by precipitating plasma with glycine |
| 06/10/2004 | US20040110685 Scatter factor/hepatocyte growth factor antagonist NK4 for the treatment of glioma |
| 06/10/2004 | US20040110684 Genetically engineered caveolin-; antiischemic, antitumor, and wound healing agents; cardiovascular and brain disorders |
| 06/10/2004 | US20040110683 Cell proliferation factor Fwa267 |
| 06/10/2004 | US20040110679 Administering erythropoietin or derivative to human suffering from diabetes |
| 06/10/2004 | US20040110678 Novel drug delivery system |
| 06/10/2004 | US20040110677 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 06/10/2004 | US20040110676 Administering huntington protein or biologically-active fragment or variant to treat Huntington's, Alzheimer's , Parkinson's , amyotrophic lateral sclerosis, multiple sclerosis, and other neurodegenerative diseases |
| 06/10/2004 | US20040110674 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |
| 06/10/2004 | US20040110673 Treatment of diseases such as diabetes with administering CD83 and T-cells for medical diagnosis and proteins |
| 06/10/2004 | US20040110672 Genetic disorders and cholera endotoxins for calcium channel activators |
| 06/10/2004 | US20040110671 N-terminal modified recombinant human endostatin and its production |
| 06/10/2004 | US20040110670 Heterologous expression of neisserial proteins |
| 06/10/2004 | US20040110669 Destruction of prions using vibriolysin or variants thereof |
| 06/10/2004 | US20040110668 Nucleic acid sequences differentially expressed in cancer tissue |
| 06/10/2004 | US20040110667 Carrier system for cyclosporin pharmaceutical compositions |
| 06/10/2004 | US20040110666 Cyclosporins for treatment of autoimmune disorders and diseases |
| 06/10/2004 | US20040110665 Oligopeptide antibiotics with leucine and sugars for treating infectionswith polypeptides. |
| 06/10/2004 | US20040110664 Acylated insulin |
| 06/10/2004 | US20040110663 Hedgehog antagonists, methods and uses related thereto |
| 06/10/2004 | US20040110662 Administering cytotoxic agent and heat shock protein 90 inhibitors such as ansamycins for synergistic growth inhibitors of cells. This therapy as cytotoxic agent and as cell growth inhibitors |
| 06/10/2004 | US20040110296 biological conjugates used for drug delivery; side effect reduction |
| 06/10/2004 | US20040110291 Modulation of adipophilin expression |
| 06/10/2004 | US20040110269 Protection against mycobacterial infections |
| 06/10/2004 | US20040110263 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment or diagnosis of atherosclerosis |
| 06/10/2004 | US20040110238 Constitutively activated human G protein coupled receptors |
| 06/10/2004 | US20040110235 for the treatment of diabetes and other diseases using systematic evolution of ligands by exponential enrichment (SELEX) |
| 06/10/2004 | US20040110218 BMOG, a novel protein member of the myelin-oligodendrocyte glycoprotein family and its use for immunomodulatory purposes |
| 06/10/2004 | US20040110181 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 06/10/2004 | US20040110180 Comprises enzymatic polypeptide for diagnosis, treatment and prevention of cardiovascular, immune system, nervous system, lipid and cell proliferative disorders; drug screening |
| 06/10/2004 | US20040110175 Comprises nucleotide sequences coding protein for use in treatment, diagnosis and prevention of nervous system disorders and neurodegenerative diseases; neuroprotectants |
| 06/10/2004 | US20040110168 Diagnostics and therapeutics for osteoporosis |
| 06/10/2004 | US20040110164 L-methionine $g(g)-lyase with modified function |
| 06/10/2004 | US20040110160 Modulation of SEDL expression |
| 06/10/2004 | US20040110159 Antisense oligonucleotides for controlling expression of estrogen responsive transcription factor and for treatment of hyperproliferative disorders |
| 06/10/2004 | US20040110158 Modulation of mitochondrial ribosomal protein L13 expression |
| 06/10/2004 | US20040110157 Antisense oligonucleotides for controlling expression of thiolase and for treatment of disorders asociated with elevated cholesterol |
| 06/10/2004 | US20040110156 Antisense oligonucleotides for controlling expression of nuclear factor-kappaB repressing factor (NRF) and for treatment of immunological disorders |